{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:24Z","timestamp":1790802684102,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xkme.2025.101080","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:53:02Z","timestamp":1754452382000},"page":"101080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monitoring, Control, and Clinical Outcomes Associated With Chronic Kidney Disease-Mineral Bone Disorder: A Population-Based Cohort Study in Ontario, Canada"],"prefix":"10.1016","volume":"7","author":[{"given":"Akshay","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-5597","authenticated-orcid":false,"given":"Kristin K.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2025.101080_bib1","doi-asserted-by":"crossref","DOI":"10.2147\/IJNRD.S191156","article-title":"Chronic kidney disease\u2013mineral and bone disorder (CKD-MBD): current perspectives","volume":"12","author":"Waziri","year":"2019","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"10.1016\/j.xkme.2025.101080_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00198-019-05190-5","article-title":"The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis","volume":"31","author":"Goto","year":"2020","journal-title":"Osteoporos Int"},{"issue":"85","key":"10.1016\/j.xkme.2025.101080_bib3","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1046\/j.1523-1755.63.s85.26.x","article-title":"Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population","author":"Marco","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.xkme.2025.101080_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2012.00095","article-title":"Mechanisms and clinical consequences of vascular calcification","volume":"3","author":"Zhu","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Pt B","key":"10.1016\/j.xkme.2025.101080_bib5","article-title":"Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications","volume":"311","author":"Kaur","year":"2022","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.xkme.2025.101080_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2025.101080_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00223-021-00844-1","article-title":"Vitamin D supplementation for patients with chronic kidney disease: a systematic review and meta-analyses of trials investigating the response to supplementation and an overview of guidelines","volume":"109","author":"Christodoulou","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"10.1016\/j.xkme.2025.101080_bib9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/ijerph15081773","article-title":"Vitamin D deficiency in chronic kidney disease: recent evidence and controversies","volume":"15","author":"Gois","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.xkme.2025.101080_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/0886022X.2015.1043920","article-title":"Vitamin D supplements in chronic kidney disease","volume":"37","author":"Zhu","year":"2015","journal-title":"Ren Fail"},{"issue":"4","key":"10.1016\/j.xkme.2025.101080_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2025.101080_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The Reporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101080_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12927\/hcq.2016.24691","article-title":"Epidemiology of fracture in adults from Ontario, Canada, with chronic kidney disease: an examination of fracture burden using administrative health data","volume":"19","author":"Naylor","year":"2016","journal-title":"Healthc Q"},{"issue":"1","key":"10.1016\/j.xkme.2025.101080_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001921","article-title":"Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes","volume":"3","author":"Gandhi","year":"2013","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.xkme.2025.101080_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2215\/CJN.16171221","article-title":"Fracture risk of sodium-glucose cotransporter-2 inhibitors in chronic kidney disease","volume":"17","author":"Cowan","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101080_bib16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ekir.2021.02.019","article-title":"Incidence of major adverse cardiovascular events and cardiac mortality in high-risk kidney-only and simultaneous pancreas\u2212kidney transplant recipients","volume":"6","author":"Lim","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.xkme.2025.101080_bib17","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","article-title":"Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease","volume":"30","author":"Geng","year":"2019","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.xkme.2025.101080_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2025.101080_bib20","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101080_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/j.ajkd.2020.10.008","article-title":"Design and rationale of HiLo: a pragmatic, randomized trial of phosphate management for patients receiving maintenance hemodialysis","volume":"77","author":"Edmonston","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.xkme.2025.101080_bib22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","article-title":"Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD","volume":"25","author":"Kovesdy","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.xkme.2025.101080_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneph.2017.60","article-title":"Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD","volume":"13","author":"Haarhaus","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2025.101080_bib24","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/jcm12072714","article-title":"Osteomalacia in adults: a practical insight for clinicians","volume":"12","author":"Arboleya","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101080_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfad190","article-title":"Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients","volume":"39","author":"Barrera-Baena","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.xkme.2025.101080_bib26","first-page":"1095","article-title":"Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis","volume":"38","author":"Pan","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Bao"},{"issue":"10","key":"10.1016\/j.xkme.2025.101080_bib27","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.ekir.2024.07.008","article-title":"Lower parathyroid hormone levels are associated with reduced fracture risk in japanese patients on hemodialysis","volume":"9","author":"Komaba","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.xkme.2025.101080_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1681\/ASN.2004080697","article-title":"Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance","volume":"16","author":"Garg","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:32:53Z","timestamp":1772915573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2590059525001165"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101080","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring, Control, and Clinical Outcomes Associated With Chronic Kidney Disease-Mineral Bone Disorder: A Population-Based Cohort Study in Ontario, Canada","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101080"}}